This afternoon, the Senate will vote on sweeping patent reform measures that are pleasing tech companies but worrying pharma and biopharma (more on this from the Houston Chronicle). Read a report The Department of Justice and FTC released a comprehensive report on the subject this morning, while Bloomberg's Washington correspondent provided this brief update.
Bloomberg - (BLOOM)
Apr. 18, 2007. 12:54 PM EST
What will it mean for the biotech industry?